News & Updates

STEMI hospitalizations down during pandemic
STEMI hospitalizations down during pandemic
26 Dec 2021
Ticagrelor monotherapy following short-term DAPT more suitable for seniors with ACS
Ticagrelor monotherapy following short-term DAPT more suitable for seniors with ACS
25 Dec 2021

For older acute coronary syndrome (ACS) patients with implanted bioabsorbable polymer sirolimus-eluting stents, a strategy involving ticagrelor monotherapy after 3‐month dual antiplatelet therapy (DAPT) is better than ticagrelor‐based 12‐month DAPT, according to a post hoc analysis of the TICO* trial. Furthermore, the beneficial effect of ticagrelor monotherapy increases with age and is strongest among patients aged ≥64 years.

Ticagrelor monotherapy following short-term DAPT more suitable for seniors with ACS
25 Dec 2021